3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
16
Carcinoma, Non-Small-Cell Lung
16
Breast Neoplasms
14
Triple Negative Breast Neoplasms
12
Lung Neoplasms
12
Neoplasm Metastasis
11
Squamous Cell Carcinoma of Head and Neck
8
Ovarian Neoplasms
8
Endometrial Neoplasms
7
Fallopian Tube Neoplasms
6
Esophageal Neoplasms
5
Oropharyngeal Neoplasms
4
Neoplasms
4
Melanoma
4
Colorectal Neoplasms
4
Adenocarcinoma Of Esophagus
4
Mouth Neoplasms
3
Laryngeal Neoplasms
3
Cholangiocarcinoma
3
Carcinoma, Transitional Cell
3
Carcinoma
3
Inflammatory Breast Neoplasms
2
Hypopharyngeal Neoplasms
2
Head and Neck Neoplasms
2
Gallbladder Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Brenner Tumor
2
Anatomic Stage II Breast Cancer AJCC v8
2
Anatomic Stage I Breast Cancer AJCC v8
2
Adenocarcinoma
2
Interventions
Nivolumab
3
tivozanib
1
regorafenib
1
neratinib
1
lutetium Lu 177 dotatate
1
encorafenib
1
durvalumab
1
capivasertib
1
Valproic Acid
1
Thioctic Acid
1
Oxaliplatin
1
Multiparametric Magnetic Resonance Imaging
1
Leucovorin
1
Lenalidomide
1
Gemcitabine
1
Fulvestrant
1
Folfox protocol
1
Fluorouracil
1
Cisplatin
1
Cetuximab
1
Bortezomib
1
Blood Specimen Collection
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Disease Progression
×
Taxes
×
90 days
×
Clear all
No trials found.